These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32086528)

  • 21. Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
    Liau WS; Tan SH; Ngoc PCT; Wang CQ; Tergaonkar V; Feng H; Gong Z; Osato M; Look AT; Sanda T
    Leukemia; 2017 Aug; 31(8):1798-1807. PubMed ID: 28028313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.
    Ngoc PCT; Tan SH; Tan TK; Chan MM; Li Z; Yeoh AEJ; Tenen DG; Sanda T
    Leukemia; 2018 Oct; 32(10):2138-2151. PubMed ID: 29654272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains.
    Khoury A; Achinger-Kawecka J; Bert SA; Smith GC; French HJ; Luu PL; Peters TJ; Du Q; Parry AJ; Valdes-Mora F; Taberlay PC; Stirzaker C; Statham AL; Clark SJ
    Nat Commun; 2020 Jan; 11(1):54. PubMed ID: 31911579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active enhancers strengthen insulation by RNA-mediated CTCF binding at chromatin domain boundaries.
    Islam Z; Saravanan B; Walavalkar K; Farooq U; Singh AK; Radhakrishnan S; Thakur J; Pandit A; Henikoff S; Notani D
    Genome Res; 2023 Jan; 33(1):1-17. PubMed ID: 36650052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
    Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
    Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Many facades of CTCF unified by its coding for three-dimensional genome architecture.
    Wu Q; Liu P; Wang L
    J Genet Genomics; 2020 Aug; 47(8):407-424. PubMed ID: 33187878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5C analysis of the Epidermal Differentiation Complex locus reveals distinct chromatin interaction networks between gene-rich and gene-poor TADs in skin epithelial cells.
    Poterlowicz K; Yarker JL; Malashchuk I; Lajoie BR; Mardaryev AN; Gdula MR; Sharov AA; Kohwi-Shigematsu T; Botchkarev VA; Fessing MY
    PLoS Genet; 2017 Sep; 13(9):e1006966. PubMed ID: 28863138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
    Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
    Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outward-oriented sites within clustered CTCF boundaries are key for intra-TAD chromatin interactions and gene regulation.
    Ge X; Huang H; Han K; Xu W; Wang Z; Wu Q
    Nat Commun; 2023 Dec; 14(1):8101. PubMed ID: 38062010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTCF mediates dosage- and sequence-context-dependent transcriptional insulation by forming local chromatin domains.
    Huang H; Zhu Q; Jussila A; Han Y; Bintu B; Kern C; Conte M; Zhang Y; Bianco S; Chiariello AM; Yu M; Hu R; Tastemel M; Juric I; Hu M; Nicodemi M; Zhuang X; Ren B
    Nat Genet; 2021 Jul; 53(7):1064-1074. PubMed ID: 34002095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.
    Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S
    Technol Cancer Res Treat; 2020; 19():1533033820934130. PubMed ID: 32633635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth.
    Sharma A; Mistriel-Zerbib S; Najar RA; Engal E; Bentata M; Taqatqa N; Dahan S; Cohen K; Jaffe-Herman S; Geminder O; Baker M; Nevo Y; Plaschkes I; Kay G; Drier Y; Berger M; Salton M
    PLoS Biol; 2023 Jun; 21(6):e3002175. PubMed ID: 37379322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pushing the TAD boundary: Decoding insulator codes of clustered CTCF sites in 3D genomes.
    Huang H; Wu Q
    Bioessays; 2024 Oct; 46(10):e2400121. PubMed ID: 39169755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between CTCF boundaries and a super enhancer controls cohesin extrusion trajectories and gene expression.
    Vos ESM; Valdes-Quezada C; Huang Y; Allahyar A; Verstegen MJAM; Felder AK; van der Vegt F; Uijttewaal ECH; Krijger PHL; de Laat W
    Mol Cell; 2021 Aug; 81(15):3082-3095.e6. PubMed ID: 34197738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatin topology and the timing of enhancer function at the
    Rodríguez-Carballo E; Lopez-Delisle L; Willemin A; Beccari L; Gitto S; Mascrez B; Duboule D
    Proc Natl Acad Sci U S A; 2020 Dec; 117(49):31231-31241. PubMed ID: 33229569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
    Tan SH; Tan TK; Yokomori R; Liao M; Huang XZ; Yeoh AEJ; Sanda T
    Leukemia; 2023 Oct; 37(10):1969-1981. PubMed ID: 37591943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A TAD boundary is preserved upon deletion of the CTCF-rich Firre locus.
    Barutcu AR; Maass PG; Lewandowski JP; Weiner CL; Rinn JL
    Nat Commun; 2018 Apr; 9(1):1444. PubMed ID: 29654311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.
    Lupey-Green LN; Caruso LB; Madzo J; Martin KA; Tan Y; Hulse M; Tempera I
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation.
    Steiner M; Schneider L; Yillah J; Gerlach K; Kuvardina ON; Meyer A; Maring A; Bonig H; Seifried E; Zörnig M; Lausen J
    PLoS One; 2019; 14(1):e0210515. PubMed ID: 30653565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
    Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
    Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.